| Scott E Hansen, MD | |
|
3570 W 9000 S, #210, West Jordan, UT 84088-8876 | |
| (801) 569-2626 | |
| (801) 569-5333 |
| Full Name | Scott E Hansen |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 35 Years |
| Location | 3570 W 9000 S, West Jordan, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164402897 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2612711205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Valley Women's Health Care Pc | 7810927241 | 10 |
News Archive
Scientists at the University of California at Berkeley have devised a method by which they can hear thoughts. They conducted a small study in which they could predict what people were thinking based on their brain activity.
Tegal Corporation today announced that its recently acquired CollabRx, Inc., subsidiary signed an exclusive license agreement to provide a version of its proprietary Therapy Finder tool to MedPage Today, Everyday Health, Inc.'s rapidly growing online site that serves 96% of all oncologists and 1.6 million monthly online unique users.
Physicians and scientists are constantly on the lookout for new disease genes that can help them understand why patients have undiagnosed medical problems.
Anavex Life Sciences Corp. is pleased to announce that it has raised $1,575,000 through the exercise of warrants. Funds will be used to continue the Phase I clinical trial of ANAVEX 2-73, the company's lead drug candidate for Alzheimer's disease, to advance other compounds in the Anavex pipeline, and for general corporate purposes.
› Verified 1 days ago
| Entity Name | South Valley Women's Health Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750460259 PECOS PAC ID: 7810927241 Enrollment ID: O20050816000630 |
News Archive
Scientists at the University of California at Berkeley have devised a method by which they can hear thoughts. They conducted a small study in which they could predict what people were thinking based on their brain activity.
Tegal Corporation today announced that its recently acquired CollabRx, Inc., subsidiary signed an exclusive license agreement to provide a version of its proprietary Therapy Finder tool to MedPage Today, Everyday Health, Inc.'s rapidly growing online site that serves 96% of all oncologists and 1.6 million monthly online unique users.
Physicians and scientists are constantly on the lookout for new disease genes that can help them understand why patients have undiagnosed medical problems.
Anavex Life Sciences Corp. is pleased to announce that it has raised $1,575,000 through the exercise of warrants. Funds will be used to continue the Phase I clinical trial of ANAVEX 2-73, the company's lead drug candidate for Alzheimer's disease, to advance other compounds in the Anavex pipeline, and for general corporate purposes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott E Hansen, MD 3570 W 9000 S, #210, West Jordan, UT 84088-8876 Ph: (801) 569-2626 | Scott E Hansen, MD 3570 W 9000 S, #210, West Jordan, UT 84088-8876 Ph: (801) 569-2626 |
News Archive
Scientists at the University of California at Berkeley have devised a method by which they can hear thoughts. They conducted a small study in which they could predict what people were thinking based on their brain activity.
Tegal Corporation today announced that its recently acquired CollabRx, Inc., subsidiary signed an exclusive license agreement to provide a version of its proprietary Therapy Finder tool to MedPage Today, Everyday Health, Inc.'s rapidly growing online site that serves 96% of all oncologists and 1.6 million monthly online unique users.
Physicians and scientists are constantly on the lookout for new disease genes that can help them understand why patients have undiagnosed medical problems.
Anavex Life Sciences Corp. is pleased to announce that it has raised $1,575,000 through the exercise of warrants. Funds will be used to continue the Phase I clinical trial of ANAVEX 2-73, the company's lead drug candidate for Alzheimer's disease, to advance other compounds in the Anavex pipeline, and for general corporate purposes.
› Verified 1 days ago
Katherine Peacock, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3181 W 9000 S, West Jordan, UT 84088 Phone: 801-569-5500 | |
Frances Bechek, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3570 W 9000 S, #210, West Jordan, UT 84088 Phone: 801-569-2626 Fax: 801-569-5333 | |
Spencer N Colby, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3584 W 9000 S, Ste 206, West Jordan, UT 84088 Phone: 801-561-2227 | |
Scott F Epstein, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3584 W 9000 S, Ste 206, West Jordan, UT 84088 Phone: 801-561-2227 Fax: 801-561-5353 | |
Amanda M. Cleveland, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3584 W 9000 S, Suite 206, West Jordan, UT 84088 Phone: 801-561-2227 | |
Denise Jean Boudreaux-nippert, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3584 W 9000 S, Suite 206, West Jordan, UT 84088 Phone: 801-561-2227 Fax: 801-561-5353 |